UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Lack of an association between clinical INSTI-related body weight gain and direct interference with MC4 receptor (MC4R), a key central regulator of body weight

PloS one, 2020-02, Vol.15 (2), p.e0229617-e0229617

2020

Volltextzugriff (PDF)

Leptin responsiveness restored by amylin agonism in diet-induced obesity: Evidence from nonclinical and clinical studies

Proceedings of the National Academy of Sciences - PNAS, 2008-05, Vol.105 (20), p.7257-7262

2008

Volltextzugriff (PDF)

Targeting lipid biosynthesis pathways for hepatitis B virus cure

PloS one, 2022-08, Vol.17 (8), p.e0270273-e0270273

2022

Volltextzugriff (PDF)

Rapid development of non-alcoholic steatohepatitis in Psammomys obesus (Israeli sand rat)

PloS one, 2014-03, Vol.9 (3), p.e92656-e92656

2014

Volltextzugriff (PDF)

Improved glucose control and reduced body weight in rodents with dual mechanism of action peptide hybrids

PloS one, 2013-10, Vol.8 (10), p.e78154-e78154

2013

Volltextzugriff (PDF)

Targeting lipid biosynthesis pathways for hepatitis B virus cure

PloS one, 2022-08, Vol.17 (8)

2022

Volltextzugriff (PDF)

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis (NASH) Resolution

Journal of visualized experiments, 2019-04 (146)

2019

Volltextzugriff (PDF)

1813-P: Coadministration of a GLP-1/Glucagon Receptor Agonist with an FXR Agonist and ACC Inhibitor Reverses Nonalcoholic Steatohepatitis (NASH) in Diet-Induced and Biopsy-Confirmed Mice

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Volltextzugriff (PDF)

1810-P: Triple Combination Therapy of GLP-1 Receptor Agonist Semaglutide with an FXR Agonist and AC Inhibitor Reverses Nonalcoholic Steatohepatitis (NASH) in Diet-Induced and Biopsy-Confirmed Mice

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Volltextzugriff (PDF)

1820-P: A Direct AMPK Activator Reduces Liver Steatosis in a Mouse Model of NASH

Diabetes (New York, N.Y.), 2020-06, Vol.69 (Supplement_1)

2020

Volltextzugriff (PDF)

Differential Effects of a Glucagon-Like Peptide 1 Receptor Agonist in Non-Alcoholic Fatty Liver Disease and in Response to Hepatectomy

Scientific reports, 2018-11, Vol.8 (1), p.16461-15, Article 16461

2018

Volltextzugriff (PDF)

Engineering of a GLP-1 analogue peptide/anti-PCSK9 antibody fusion for type 2 diabetes treatment

Scientific reports, 2018-12, Vol.8 (1), p.17545-14, Article 17545

2018

Volltextzugriff (PDF)

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis (NASH) Resolution

Journal of visualized experiments, 2019-04 (146)

2019

Volltextzugriff (PDF)

Lack of an association between clinical INSTI-related body weight gain and direct interference with MC4 receptor

PloS one, 2020-02, Vol.15 (2), p.e0229617

2020

Volltextzugriff (PDF)

Weighing in on synergy: Preclinical research on neurohormonal anti-obesity combinations : Neurobiology of obesity

Brain research, 2010, Vol.1350, p.86-94

2010

Volltextzugriff (PDF)

Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indices of nonalcoholic steatohepatitis in mice

American journal of physiology: Gastrointestinal and liver physiology, 2012, Vol.65 (4)

2012

Volltextzugriff (PDF)

Mechanism of Amylin/Leptin Synergy in Rodent Models

Endocrinology (Philadelphia), 2010, Vol.151 (1), p.143-152

2010

Volltextzugriff (PDF)

Effects of prior or concurrent food restriction on amylin-induced changes in body weight and body composition in high-fat-fed female rats

American journal of physiology: endocrinology and metabolism, 2007, Vol.56 (4)

2007

Volltextzugriff (PDF)

Role of Adiponectin and Inflammation in Insulin Resistance of Mc3r and Mc4r Knockout Mice

Obesity research, 2007, Vol.15 (11), p.2664-2672

2007

Volltextzugriff (PDF)

Neuroendocrine Control of Food Intake

Overweight and the Metabolic Syndrome, p.1-21

Volltextzugriff (PDF)

Functionalisation of brush polyethylene glycol polymers with specific lipids extends their elimination half-life through association with natural lipid trafficking pathways

Acta biomaterialia, 2024-01, Vol.174, p.191-205

2024

Volltextzugriff (PDF)

Pancreatic ß-Cell Rest Replenishes Insulin Secretory Capacity and Attenuates Diabetes in an Extreme Model of Obese Type 2 Diabetes

Diabetes (New York, N.Y.), 2019-01, Vol.68 (1), p.131

2019

Volltextzugriff (PDF)

1 – 23 von 23

Suche als RSS-Feed

Aktive Filter

ThemaLife Sciences & Biomedicine

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(22)
Buchkapitel
(1)

Sprache

Englisch
(23)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Lack of an association between clinical INSTI-related body weight gain and direct interference with MC4 receptor (MC4R), a key central regulator of body weight

Leptin responsiveness restored by amylin agonism in diet-induced obesity: Evidence from nonclinical and clinical studies

Targeting lipid biosynthesis pathways for hepatitis B virus cure

Rapid development of non-alcoholic steatohepatitis in Psammomys obesus (Israeli sand rat)

Improved glucose control and reduced body weight in rodents with dual mechanism of action peptide hybrids

Targeting lipid biosynthesis pathways for hepatitis B virus cure

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis (NASH) Resolution

1813-P: Coadministration of a GLP-1/Glucagon Receptor Agonist with an FXR Agonist and ACC Inhibitor Reverses Nonalcoholic Steatohepatitis (NASH) in Diet-Induced and Biopsy-Confirmed Mice

1810-P: Triple Combination Therapy of GLP-1 Receptor Agonist Semaglutide with an FXR Agonist and AC Inhibitor Reverses Nonalcoholic Steatohepatitis (NASH) in Diet-Induced and Biopsy-Confirmed Mice

1820-P: A Direct AMPK Activator Reduces Liver Steatosis in a Mouse Model of NASH

Differential Effects of a Glucagon-Like Peptide 1 Receptor Agonist in Non-Alcoholic Fatty Liver Disease and in Response to Hepatectomy

Engineering of a GLP-1 analogue peptide/anti-PCSK9 antibody fusion for type 2 diabetes treatment

Incorporation of a Survivable Liver Biopsy Procedure in Mice to Assess Non-alcoholic Steatohepatitis (NASH) Resolution

Lack of an association between clinical INSTI-related body weight gain and direct interference with MC4 receptor

Peptide-YY 3-36 /glucagon-like peptide-1 combination treatment of obese diabetic mice improves insulin sensitivity associated with recovered pancreatic β-cell function and synergistic activation of discrete hypothalamic and brainstem neuronal circuitries

Weighing in on synergy: Preclinical research on neurohormonal anti-obesity combinations : Neurobiology of obesity

Glucagon-like peptide-1 receptor agonism improves metabolic, biochemical, and histopathological indices of nonalcoholic steatohepatitis in mice

Mechanism of Amylin/Leptin Synergy in Rodent Models

Effects of prior or concurrent food restriction on amylin-induced changes in body weight and body composition in high-fat-fed female rats

Role of Adiponectin and Inflammation in Insulin Resistance of Mc3r and Mc4r Knockout Mice

Neuroendocrine Control of Food Intake

Functionalisation of brush polyethylene glycol polymers with specific lipids extends their elimination half-life through association with natural lipid trafficking pathways

Pancreatic ß-Cell Rest Replenishes Insulin Secretory Capacity and Attenuates Diabetes in an Extreme Model of Obese Type 2 Diabetes

Aktive Filter

Suchergebnisse filtern